ALTHE · Theraclion SA
0.71
EURUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Euro52.09M
PE
0.00
EV/EBITDA
N/A
DIV Yield
0%
Payout Ratio
0%
MQV Rating
5Very Weak
As at 21/09/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- HALO All
- HALO Small
Key Fundamentals
EPS 3 yr Growth
-43.70%
EBITDA Margin
-505.10%
Operating Cashflow
€0m
Free Cash Flow Return
0.00%
ROIC
-429.80%
Interest Coverage
-37.00
Quick Ratio
1.50
Performance
52 weeks range
Low 0.4 - 0.93
Trade Value (12mth)
US$21,258.00
1 week
8.9%
1 month
9.74%
YTD
16.39%
1 year
-16.86%
All time high
13.35
Additional Data
Shares Outstanding (Fully Diluted)
73m
HALO Sector
Healthcare
Next Company Report Date
29-Apr-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
EUR
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Very Weak
Momentum
Price
Weak
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Bernard Sabrier | Individual |
| Inner Mongolia Furui Medical Science Co., Ltd. | Public Company |
| Théraclion SA | Public Company |
